The Week Ahead In Biotech (April 11-17): Avenue Therapeutics FDA Decision and Conference Presentations In The Spotlight
美股周报 | 道指、标指齐创新高，4月强劲开局或将持续整月
SPAC到底是个啥？它到底牛在哪里？
股市杠杆增速突破20年来最高值！彭博：高杠杆不意味市场将崩盘
百济神州总裁吴晓滨：PD-1产能相当一段时间内不会过剩
BRIEF-Beigene Provides Update On Phase 2 Clinical Trial Of Zanubrutinib In Patients With Covid-19-Related Pulmonary Distress
百济神州公布百悦泽(R)用于治疗出现呼吸窘迫的新型冠状病毒肺炎患者的2期临床试验最新进展
BeiGene Provides Update on Phase 2 Clinical Trial of Zanubrutinib in Patients with COVID-19-Related Pulmonary Distress; Co. Reports 'Trial did not meet the co-primary efficacy endpoints; no new safet
BeiGene Launches BRUKINSA in Canada for Patients with Waldenström's Macroglobulinemia
百济神州：广州生物药生产基地正式启动商业化生产暨启动供货
